Doximity, Inc.

NYSE:DOCS Lagerbericht

Marktkapitalisierung: US$7.9b

Doximity Management

Management Kriterienprüfungen 3/4

Doximity's CEO is Jeff Tangney, appointed in Apr 2010, has a tenure of 14.58 years. total yearly compensation is $298.87K, comprised of 98.7% salary and 1.3% bonuses, including company stock and options. directly owns 27.35% of the company’s shares, worth $2.15B. The average tenure of the management team and the board of directors is 3.8 years and 9.2 years respectively.

Wichtige Informationen

Jeff Tangney

Geschäftsführender

US$298.9k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts98.7%
Amtszeit als Geschäftsführer14.6yrs
Eigentum des Geschäftsführers27.3%
Durchschnittliche Amtszeit des Managements3.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder9.2yrs

Jüngste Management Updates

Recent updates

Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?

Nov 02
Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 15
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity: Downgrade To Hold On Valuation Concerns

Oct 03

Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors

Sep 23
Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors

There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Aug 18
There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Aug 10
Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Doximity Faces Slower Revenue Growth As R&D Costs May Rise

Jul 23

Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

Jul 23
Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Jul 01
At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Jun 09
Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)

May 17

Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

May 04
Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

Doximity: Significant Upside Remains, But Not Until The Growth Story Returns

Apr 29

With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Apr 16
With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Mar 26
Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: Rating Upgrade To Buy As Outlook Turns Positive

Feb 21

We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

Feb 15
We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Feb 13
What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan

Jan 16

Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Jan 04
Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Dec 14
Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Doximity: Adding Value Using AI But Faces Near-Term Risks

Nov 01

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 30
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Sep 25
Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

Aug 24

Doximity Earnings: Too Many Problems, Sell

Aug 09

A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Jul 29
A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Jul 09
Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Doximity: Continue To See Positive Upside From Current Stock Level

Jul 05

The Returns At Doximity (NYSE:DOCS) Aren't Growing

Jun 21
The Returns At Doximity (NYSE:DOCS) Aren't Growing

Doximity: Digital Health Play With Strong Fundamentals

Jun 21

A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Apr 07
A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Mar 20
Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Doximity: Good Business But Extremely Overvalued

Feb 18

Doximity Q3 Earnings: Disappointing Results

Feb 10

Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Dec 25
Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: On The Right Path To Further Consolidate Market Share

Dec 22

Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Dec 04
Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Jeff Tangney im Vergleich zu den Einnahmen von Doximity verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

US$161m

Mar 31 2024US$299kUS$295k

US$148m

Dec 31 2023n/an/a

US$138m

Sep 30 2023n/an/a

US$123m

Jun 30 2023n/an/a

US$119m

Mar 31 2023US$244kUS$240k

US$113m

Dec 31 2022n/an/a

US$119m

Sep 30 2022n/an/a

US$141m

Jun 30 2022n/an/a

US$148m

Mar 31 2022US$243kUS$240k

US$133m

Dec 31 2021n/an/a

US$107m

Sep 30 2021n/an/a

US$57m

Jun 30 2021n/an/a

US$30m

Mar 31 2021US$21mUS$240k

US$22m

Vergütung im Vergleich zum Markt: Jeff's total compensation ($USD298.87K) is below average for companies of similar size in the US market ($USD8.03M).

Entschädigung vs. Einkommen: Jeff's compensation has increased by more than 20% in the past year.

Geschäftsführer

Jeff Tangney (51 yo)

14.6yrs

Amtszeit

US$298,869

Vergütung

Mr. Jeffrey A. Tangney, also known as Jeff, Co-Founded Doximity, Inc. in 2010 and has been its Chief Executive Officer and Director since April 2010 and serves as its Chairperson. Mr. Tangney also serves a...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Jeffrey Tangney
Co-Founder14.6yrsUS$298.87k27.35%
$ 2.2b
Nate Gross
Co-Founder & Chief Strategy Officerno dataUS$305.47k0.26%
$ 20.4m
Anna Bryson
Chief Financial Officer3.8yrsUS$3.87m0.12%
$ 9.6m
Jennifer Chaloemtiarana
General Counsel & Corporate Secretary4.3yrsUS$603.94k0.0032%
$ 250.0k
Craig Overpeck
Senior Vice President of Commercial Operations1.5yrsUS$5.21m0.012%
$ 905.0k
Shari Buck
Co-founder and SVP People & Opsno datakeine Datenkeine Daten
Jey Balachandran
Chief Technology Officerno datakeine Datenkeine Daten
Perry Gold
Head of Investor Relationsno datakeine Datenkeine Daten
Jim Rivas
Head of Corporate Communicationsno datakeine Datenkeine Daten
Bruno Miranda
Senior Vice President of Engineeringno datakeine Datenkeine Daten
Joel Davis
Senior Vice President of Productno datakeine Datenkeine Daten
Ben Greenberg
Senior VP & GM Commercial Products1.5yrskeine Datenkeine Daten

3.8yrs

Durchschnittliche Betriebszugehörigkeit

45.5yo

Durchschnittliches Alter

Erfahrenes Management: DOCS's management team is considered experienced (3.8 years average tenure).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Jeffrey Tangney
Co-Founder14.6yrsUS$298.87k27.35%
$ 2.2b
Barry Chaiken
Member of Medical Advisory Boardno datakeine Datenkeine Daten
Timothy Cabral
Independent Director4.2yrsUS$239.94k0.0025%
$ 199.7k
Kevin Spain
Independent Director13.7yrsUS$241.94k0.13%
$ 10.3m
Lawrence Chin
Member of Medical Advisory Boardno datakeine Datenkeine Daten
Elise Brett
Member of Medical Advisory Boardno datakeine Datenkeine Daten
Bradley Cohn
Member of Medical Advisory Boardno datakeine Datenkeine Daten
Alexander Ding
Member of Medical Advisory Boardno datakeine Datenkeine Daten
Sharon Drost
Member of Medical Advisory Boardno datakeine Datenkeine Daten
Todd Ferris
Member of Medical Advisory Boardno datakeine Datenkeine Daten
Harvey Fishman
Member of Medical Advisory Boardno datakeine Datenkeine Daten
Kira Wampler
Independent Director4.7yrsUS$233.94k0.0055%
$ 434.8k

9.2yrs

Durchschnittliche Betriebszugehörigkeit

51.5yo

Durchschnittliches Alter

Erfahrener Vorstand: DOCS's board of directors are considered experienced (9.2 years average tenure).